Evaluating the effectiveness of the 4CMenB vaccine against invasive meningococcal disease and gonorrhoea in an infant, child and adolescent program: protocol
Invasive meningococcal disease causes significant morbidity and mortality worldwide, with serogroup B being one of the predominant serogroups in Australia for many years. The South Australian (SA) State Government recently funded the introduction of a 4CMenB vaccination program for infants, children...
Saved in:
Main Authors: | Helen S. Marshall (Author), Prabha H. Andraweera (Author), Bing Wang (Author), Mark McMillan (Author), Ann P. Koehler (Author), Noel Lally (Author), Sara Almond (Author), Emma Denehy (Author), Michele A'Houre (Author), Lynne C. Giles (Author), Louise Flood (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2021-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Characteristics of YouTube videos about the meningococcal B vaccine (4CMenB)
by: Ignacio Hernández-García, et al.
Published: (2020) -
Evolution of strain coverage by the multicomponent meningococcal serogroup B vaccine (4CMenB) in France
by: Eva Hong, et al.
Published: (2021) -
Meningococcal B vaccine (4CMenB): the journey from research to real world experience
by: Rino Rappuoli, et al.
Published: (2018) -
Adverse reactions associated with meningococcal group B vaccine (4CMenB) in adults in special situations
by: María Fernández-Prada, et al.
Published: (2018) -
Safety and immunogenicity of co-administered meningococcal serogroup B (4CMenB) vaccine: A literature review
by: Véronique Abitbol, et al.
Published: (2023)